Viking Therapeutics Sets Terms For Downsized $22.5M IPO
California-based Viking Therapeutics Inc. set terms Friday on a downsized initial public offering that seeks to raise $22.5 million, down from a previous estimate of $60 million, to fund its pipeline...To view the full article, register now.
Already a subscriber? Click here to view full article